Literature DB >> 26635075

Validity of histology for the diagnosis of paediatric coeliac disease: a Swedish multicentre study.

Caroline Montén1, Kaj Bjelkenkrantz2, Audur H Gudjonsdottir3, Lars Browaldh4, Henrik Arnell5, Åsa Torinsson Naluai6, Daniel Agardh1.   

Abstract

OBJECTIVE Histological evaluation of intestinal biopsies for the diagnosis of coeliac disease can be challenging and compatible with risk of misdiagnosis. The aim was to evaluate the agreement of pathological diagnosis for coeliac disease in children investigated at four major paediatric university hospitals in Sweden. MATERIALS AND METHODS Intestinal duodenal biopsies were collected from 402 children at median 9.7 years (1.4-18.3 years). A pathologist at each hospital performed the primary evaluation. A designated pathologist, blinded to the primary evaluation, performed a second Marsh classification of biopsies (M0 to M3c) taken from the bulb and duodenum separately. Kappa (κ) scores between first and second evaluation determined the agreement. Plasma samples were collected at the day of intestinal biopsy and analysed for tissue transglutaminase autoantibodies (tTGA) using radioligand-binding assays. RESULTS Marsh scores were concordant in 229/356 biopsies (64%, κ = 0.52, p < 0.0001). Among discordant results, 15/127 (12%) showed M0 in distal duodenum but ≥ M2 in the bulb, whereas the opposite was true for 8/127 (6%) of the biopsies. There were fewer collected duodenal biopsies, more missing bulb biopsies and missing CD3 staining among discordant evaluations. The second evaluation revealed a Marsh score compliant with coeliac disease in 22 children of whom seven children were tTGA positive. CONCLUSIONS The variation between university hospitals on the pathological evaluation of biopsies may lead to misdiagnosis of coeliac disease in paediatric patients. Access to clinical and endoscopic information as well as tTGA levels may be useful for the pathologist to complement the evaluation in dubious cases.

Entities:  

Keywords:  Coeliac disease; Marsh classification; children; tissue transglutaminase autoantibodies

Mesh:

Year:  2015        PMID: 26635075     DOI: 10.3109/00365521.2015.1101486

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Role of proneurotensin as marker of paediatric coeliac disease.

Authors:  C Montén; Å Torinsson Naluai; D Agardh
Journal:  Clin Exp Immunol       Date:  2016-10-07       Impact factor: 4.330

Review 2.  Diagnosis of Celiac Disease: Taking a Bite Out of the Controversy.

Authors:  Justine M Turner
Journal:  Dig Dis Sci       Date:  2018-06       Impact factor: 3.199

3.  Shared Genetic Factors Involved in Celiac Disease, Type 2 Diabetes and Anorexia Nervosa Suggest Common Molecular Pathways for Chronic Diseases.

Authors:  Joanna Mostowy; Caroline Montén; Audur H Gudjonsdottir; Henrik Arnell; Lars Browaldh; Staffan Nilsson; Daniel Agardh; Åsa Torinsson Naluai
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

4.  Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP.

Authors:  M P M Adriaanse; A Mubarak; R G Riedl; F J W Ten Kate; J G M C Damoiseaux; W A Buurman; R H J Houwen; A C E Vreugdenhil
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

5.  Altered peripheral amino acid profile indicate a systemic impact of active celiac disease and a possible role of amino acids in disease pathogenesis.

Authors:  Åsa Torinsson Naluai; Ladan Saadat Vafa; Audur H Gudjonsdottir; Henrik Arnell; Lars Browaldh; Staffan Nilsson; Daniel Agardh
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

6.  Deciphering the Transcriptomic Heterogeneity of Duodenal Coeliac Disease Biopsies.

Authors:  Johannes Wolf; Edith Willscher; Henry Loeffler-Wirth; Maria Schmidt; Gunter Flemming; Marlen Zurek; Holm H Uhlig; Norman Händel; Hans Binder
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

Review 7.  Wait-and-See Approach or Gluten-Free Diet Administration-The Rational Management of Potential Coeliac Disease.

Authors:  Anna Szaflarska-Popławska
Journal:  Nutrients       Date:  2021-03-15       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.